Spruce Biosciences, Inc. Common Stock (SPRB)

Spruce Biosciences, Inc. Common Stock (SPRB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $116M; returns 1 day -1.8%, 1 week +13.9%, 1 year -65.2%.

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare neurological and endocrine disorders. The company's primary focus is on Tralesinidase Alfa (TA-ERT), an enzyme replacement therapy for Sanfilippo Syndrome Type B (MPS IIIB), an ultra-rare and fatal genetic disease.

Groups SPRB belongs to

• Biopharmaceutical
• Rare Diseases
• Biotechnology
• Clinical Stage Biopharma
• Endocrinology
• Clinical Stage
• Healthcare
• Life Sciences
• Precision Medicine
• Neurological Disorders
• Neuroscience

SPRB financial model: income statement, cash flow and balance sheet